insights_auto
Bakit tumaas ang 8NE 2.44%?
Tingnan ang Higit pang Detalyechevron_right
8NE:FRA
Lisata Therapeutics, Inc.
€0.84
arrow_upward
+2.44%(+0.020) 1D
Okt 14, 10:00:00 PM GMT+2 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 8NE...
Buksan
€0.84
Mataas
€0.84
Mababa
€0.84
Mkt. cap
11.02M
Avg. na dami
0.00
Dami
0.00
Mataas nang 52-wk
€4.34
Mababa nang 52-wk
€0.74
Bilang ng mga empleyado
21
Buksan
€0.84
Mataas
€0.84
Mababa
€0.84
Mkt. cap
11.02M
Avg. na dami
0.00
Dami
0.00
Mataas nang 52-wk
€4.34
Mababa nang 52-wk
€0.74
Bilang ng mga empleyado
21
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
TipRanks
·
6 oras ang nakalipas
Lisata Therapeutics Expands Board, Appoints Independent Director
Investing.com Canada
·
7 oras ang nakalipas
Lisata Therapeutics adds Jeffrey Farrow to board of directors By Investing.com
Stock Titan
·
7 oras ang nakalipas
A drug-company finance leader with more than 15 years in finance joins Lisata's board
Profile
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
Tungkol sa Lisata Therapeutics, Inc.
CEO-
Mga Empleyado21
Itinatag1980
HeadquartersBasking Ridge, New Jersey, Estados Unidos
Sektor-
Websitelisata.com